Nanosuspensions in Drug Delivery: Recent Advances, Patent Scenarios, and Commercialization Aspects

被引:32
作者
Chavhan, Sandip S. [1 ]
Petkar, Kailash C. [1 ]
Sawant, Krutika K. [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Drug Delivery Lab,TIFAC CORE NDDS,Ctr PG Studies, Vadodara 390001, Gujarat, India
来源
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2011年 / 28卷 / 05期
关键词
Nanosuspension; poor solubility; bioavailability; advances; patents; PARTICLE-SIZE REDUCTION; WATER-SOLUBLE DRUGS; ORAL BIOAVAILABILITY; PHARMACOKINETIC EVALUATION; TISSUE DISTRIBUTION; GRISEOFULVIN NANOPARTICLES; SOLID DISPERSION; DISSOLUTION RATE; FORMULATION; NANOCRYSTALS;
D O I
10.1615/CritRevTherDrugCarrierSyst.v28.i5.20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interest in the preparation and application of nanometer-sized materials is increasing due to their tremendous potential as a drug delivery system with wide range of applications. Recently, nanoscale systems have received much interest as a way to resolve solubility issues because of their cost-effectiveness and technical simplicity compared to liposomes and other colloidal drug carriers. Nanosuspensions have proven to be a better alternative over other approaches currently available for improving bioavailability of number of drugs with low solubility. Nanosuspensions have been extensively developed for a wide range of drugs and have been evaluated for in vitro and in vivo applications by various routes: parenteral, oral, pulmonary, topical. They have also been used for drug targeting. Different preparation methods for nanosuspensions and their application are being reported and patented. In fact, the number of products based on nanosuspension in the market and under clinical study is higher than that of other nanotechnology-based applications. This article reviews the research and recent advances in formulation, characterization, application of nanosuspensions as well as patents on nanosuspension methods.
引用
收藏
页码:447 / 488
页数:42
相关论文
共 187 条
  • [1] Abu-Izza, 2007, World Intellectual Property Organization, Patent No. [WO 2007/086911 A2, 2007086911]
  • [2] Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling
    Ali, Hany S. M.
    York, Peter
    Ali, Ahmed M. A.
    Blagden, Nicholas
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 149 (02) : 175 - 181
  • [3] [Anonymous], EMULSIONS NANOSUSPEN, DOI DOI 10.1002/jps.10590
  • [4] Predictive in silico modeling for hERG channelblockers
    Aronov, MM
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (02) : 149 - 155
  • [5] Nanosuspension technology and its applications in drug delivery
    Arunkumar, N.
    Deecaraman, M.
    Rani, C.
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (03) : 168 - 173
  • [6] Augustine J, 2005, United States patent, Patent No. [US 0238673, 0238673]
  • [7] Production and In Vitro Characterization of Solid Dosage form Incorporating Drug Nanoparticles
    Basa, Shradhanjali
    Muniyappan, Thilekkumar
    Karatgi, Pradeep
    Prabhu, Raghavendra
    Pillai, Ravi
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (11) : 1209 - 1218
  • [8] Bassil N.C., 2005, US, Patent No. [0095297 Al, 0095297]
  • [9] NANOPHARMACEUTICALS
    Bawa, Raj
    [J]. EUROPEAN JOURNAL OF NANOMEDICINE, 2010, 3 (01) : 34 - 40
  • [10] Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice
    Ben Zirar, Siham
    Astier, Alain
    Muchow, Marc
    Gibaud, Stephane
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 649 - 656